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Increased nitrotyrosine staining in kidneys from patients with Diabetic nephropathy (DM) is a serious microvascular
diabetic nephropathy. complication of diabetes mellitus. This is now the leading
Background. Proximal tubular cells produce nitric oxide cause of end-stage renal disease in the Western world.
(NOx). We have shown that under hyperglycemic conditions, Approximately 30 to 40% of the patients with type Icultured proximal tubular cells express cytochrome P450 2E1,
and 15% with type II diabetes mellitus develop end-which is capable of producing superoxide (O2x). NOx and O2x
stage renal disease and require either dialysis or renalreact to form peroxynitrite (ONOOx), a powerful oxidant.
ONOOx nitrosylates tyrosine moieties on proteins causing tis- transplantation for survival [1, 2]. Despite numerous
sue damage. Our hypothesis is that ONOOx plays a role in studies, the pathophysiology of diabetic renal disease is
early diabetic tubular damage and perhaps disease progression. not completely understood.
Methods. Renal biopsies from patients with diabetic nephrop- The natural history of DM is well known: Dipstick-
athy (DM), acute allograft rejection (AAR), acute allograft
positive proteinuria and the development of renal failuretubular necrosis (ATN), and glomerulonephritis (GN) were
[3] follow the appearance of microalbuminuria. Theseobtained. Normal kidney specimens were taken from nephrec-
processes are believed to reflect glomerular changes. Tu-tomy samples (N 5 10 for each group). The tissues were exam-
ined for the presence of nitrotyrosine using an immunoperoxi- bulointerstitial changes also play an important role in
dase technique with a polyclonal antibody. Samples were then the initiation and progression of renal failure [4]. Tubular
arbitrarily scored, and the results analyzed (analysis of variance dysfunction has been reported increasingly in patients
and Student’s t-test for unpaired data). The number of apo- with diabetes mellitus, even in the absence of microal-ptotic cells in a sample of tubules in each biopsy was also
buminuria, suggestive of the pivotal role of tubulointer-assessed.
stitium in the development of DM [5, 6]. However, theResults. The DM biopsies showed increased staining for ni-
exact mechanism underlying tubular dysfunction in dia-trotyrosine in proximal tubules (P 5 0.0001) and in the thin
limb of the loop of Henle (P 5 0.0006) compared with all other betes mellitus remains unknown.
groups. There was increased staining in the ascending and distal Tight glycemic control delays the onset [7, 8] and slows
tubules in GN as compared to DM and ATN (P 5 0.01). the progression of microvascular complication, including
Nitrotyrosine was also found in all distal tubules and collecting
nephropathy in patients with type I diabetes mellitus andducts, including normals. There was no difference in the num-
in diabetic animals [9, 10]. High glucose is therefore theber of apoptotic tubular cells in diabetics compared with con-
main determinant of initiation and progression of DM.trols.
Previous studies have documented that hyperglycemiaConclusion. To our knowledge, these data provide the first
evidence for the presence of nitrotyrosine in both normal and is associated with excessive free radical generation and
diseased kidneys. The significance of the findings in normals oxidant stress and reduction in the antioxidant status
is unclear, but could be due to activation of constitutive NOS. [11, 12]. Free radicals are highly reactive and unstable
However, the study clearly demonstrates increased production chemical species that have been implicated in mediatingof ONOOx in proximal tubules of patients with DM, and sug-
vascular and tissue damage in several diseases [13–15].gests that oxidant injury of the proximal tubules plays an impor-
One of the many consequences of oxidant stress that hastant part in the pathogenesis of DM.
been linked to diabetes mellitus is at least in part due
to altered NOx production and action [16, 17]. NOx is
synthesized by the enzyme NO synthase (NOS). ThreeKey words: diabetic nephropathy, peroxynitrite, proximal tubules, oxi-
dant injury, nitric oxide. distinct NOS isoforms have been isolated, purified, and
cloned: neuroneal, endothelial, and macrophage/vascu-Received for publication February 3, 1999
lar smooth muscle cell [18]. All isoforms of NOS haveand in revised form August 30, 1999
Accepted for publication December 2, 1999 been identified in renal proximal tubular cells [19, 20].
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in renal proximal tubular cells remains a mystery. We utes at room temperature (rabbit polyclonal antinitroty-
have recently shown that overproduction of NOx in rosine; TCS Biologicals Ltd., Bucks, UK). Immunostain-
freshly isolated proximal tubules is the mediator of hyp- ing was completed by incubation for 15 minutes in
oxic tubular injury [21–23]. Depending on the relative biotinylated antirabbit antibody and then incubated for
concentrations of NOx, O2x and availability of free oxygen 15 minutes in peroxidase-labeled streptavidin [LSAB 2
several end products can be produced such as nitrites/ kit (peroxidase); Dako Ltd., Bucks, UK]. The reaction
nitrates, Ox, NOx, and peroxynitrite (ONOOx). ONOOx sites were visualized by incubation in the chromogen 3,39
is a potent oxidant in its own right but is also extremely diaminobenzidine tetrahydrochloride for five minutes.
unstable and is metabolized to hydroxyl radicals (HOx; Five-minute buffer washes were performed between
shown later in this article). each layer using TBS buffer (pH 7.6). The nuclei were
stained lightly with Gill’s hematoxylin, and the slidesNOx 1 O2x ! ONOOx
were then mounted in DePex (BDH Chemicals, Poole,
ONOOx 1 H1 , ONOOH Dorset, UK).
Positive controls were prepared by treating normalONOOH ! HOx 1 NO2x
kidney sections with ONOOx (1 mmol/L; Upstate Bio-
NO2x, also a radical, nitrosylates tyrosine moieties, re- technology, distributed by TCS Biologicals Ltd., Bucks,
sulting in the formation of nitrotyrosine, the presence UK) after the biotin blocking stage for 30 minutes. They
of which suggests ONOOx-induced injury [22]. were then washed with TBS buffer (pH 7.6) for five
We propose that interstitial ischemia in the setting of minutes, and the process continued.
hyperglycemia causes increased generation of NOx and Negative absorption controls for the first antibody
O2x, which results in the formation of ONOOx, causing were prepared. Normal kidney sections were treated
tissue damage and hence disease progression. To test with 10 mmol/L 3-nitro-l-tyrosine (Sigma-Aldrich Com-
this hypothesis, we obtained renal biopsies from 50 pa- pany Ltd., Poole, Dorset, UK) in phosphate buffered
tients with a variety of renal disease, including DM, and saline (PBS) buffer at pH 7.4 for 30 minutes. This step
examined them for the presence of nitrotyrosine using was performed prior to addition of the first antibody and
immunohistochemical techniques. blocked the action of the first antibody.
Negative controls were also prepared to ensure against
nonspecific binding caused by the second antibody. Again,METHODS
normal kidney sections were used where instead of theTen renal biopsies from patients with proven DM were
first antibody, PBS was used. The rest of the proceduretaken. As controls, 10 patients each with the following
was then carried out as discussed previously in this ar-histologic diagnoses: rapidly progressive glomerulone-
ticle.phritis (RPGN), acute allograft tubular necrosis (ATN),
All slides were independently examined by two inves-acute allograft rejection (AAR), and normals (Con) were
tigators using a semiquantitative scoring method. Theused. All patients were biopsied between 1994 and 1995
intensity of staining was assessed in the glomerulus, prox-at the Royal London Hospital, with the indications being
imal tubule, descending limb of the loop of Henle, thickproteinuria, rapid decline in native renal function, acute
ascending limb of the loop of Henle, distal tubule, col-deterioration in allograft function, and failure of allograft
lecting duct, and interstitium. The immunohistochemicalfunction. Controls were obtained from nephrectomy
method and use of hematoxylin counterstaining ensuredspecimens of patients with renal tumors.
preservation of the morphology of the tubules, thusOne micrometer paraffin sections were cut onto Su-
allowing identification of the different parts of the neph-perfrost Plus slides and dried in the oven at 458C over-
ron in the usual way. Specifically, proximal tubules arenight. After dewaxing in xylene, endogenous peroxidase
lined by columnar cells with a brush border and indistinctwas blocked by treating the sections for 10 minutes in a
lateral borders, while distal convoluted tubules are lined3% methanolic hydrogen peroxide solution. Microwave
by linear cuboidal cells with more nuclei seen per tubularantigen retrieval was then performed on the sections,
cross-section. Intensity of staining was scored as 0, 1, 2,which involved boiling the sections in 0.01 mol/L citrate
or 3 if staining was absent, weak, heavy, or very heavy.buffer (pH 6.0) in a domestic microwave oven for 10
A random sample of 50 tubular cross-sections wasminutes. To enhance the immunostaining further, the
also examined for the presence of apoptotic cells in thesections were then subjected to a brief enzyme digestion
diabetic and nephrectomy control groups. Apoptoticstep–incubation in 0.1% trypsin in 0.1% aqueous calcium
cells were easily visualized in hematoxylin-stained sec-chloride (pH 7.8) for one minute at 378C. Endogenous
tions as cells in which there were rounded condensationsbiotin and avidin were blocked by sequential 15-minute
of chromatin with a distinctive ground-glass quality, usu-treatments in 0.1% avidin and 0.1% biotin. The primary
antibody was applied at a dilution of 1/1000 for 30 min- ally attached to nuclear membrane.
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Table 1. Patient demographic data
Group Male/female Median age (range) Most recent creatinine lmol/L Last creatinine lmol/L
DM 5/5 59.5 (38–68) 200 600
ATN 5/5 43.5 (31–71) 1000 124
AAR 8/2 35.5 (22–66) 1000 145
RPGN 5/5 25 (7–73) 136.5 206
Control 8/2 62 (43–76)
Abbreviations are: DM, diabetes mellitus; ATN, acute tubular necrosis; AAR, acute allograft rejection; RPGN, rapidly progressive glomerulonephritis.
Fig. 1. Immunohistochemical staining with antinitrotyrosine in an
acutely inflamed appendix used as a positive control. The cytoplasm of
polymorphonuclear leukocytes stains intensely (1) unlike that of
smooth muscle cells (–; magnification 3120).
Statistical analysis was by analysis of variance (ANOVA)
and Student’s t-test for unpaired data.
RESULTS
The diabetic patients were the oldest of the groups
biopsied, and the youngest were the RPGN (Table 1).
Diabetic patients had the lowest serum creatinines at
Fig. 5. Immunohistochemical staining with antinitrotyrosine showingthe time of biopsy and the highest current creatinine, but
intense granular positivity in both proximal (PT) and distal tubulesthere was no significant difference between the groups.
(DT) in diabetic nephropathy (top). In nephrectomy tissue (bottom),
There were comparable number of males and females absent or weak staining is seen in the proximal tubules, with heavy
granular positivity in distal tubular cell cytoplasm (top, 3120; bottom,in the groups.
375).All positive controls showed specific staining for ni-
trotyrosine (Fig. 1). Both groups of negative controls
showed no evidence of staining, thereby ensuring any stain-
ing in samples to be due to the presence of nitrotyrosine. plasm of cells lining the collecting ducts, in mesangial
The DM biopsies showed heavy granular staining for cells within the glomerulus, and in inflammatory cells
nitrotyrosine in the cytoplasm of proximal tubular cells within the interstitium in both groups (P 5 NS). Cyto-
(P 5 0.0001; Figs. 2 and 5). There was little or no staining plasmic staining for nitrotyrosine was strongest in the
in the proximal tubules in the other four groups. In the distal tubules and in the collecting ducts; however, there
thin limb of the loop of Henle, there was nitrotyrosine was no difference between the groups (distal tubule data;
staining of a similar pattern (P 5 0.0006; Figs. 3 and 5). Fig. 4). There was no difference in the number of apo-
It was of interest that in ATN, despite ischemia, there ptotic cells in the diabetic and control groups, as only
was no evidence for ONOOx-induced injury. The pres- occasional apoptotic cells were seen in a few patients
and controls (Fig. 5).ence of nitrotyrosine was detected equally in the cyto-
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Fig. 2. Nitrotyrosine staining in proximal tubules.
Fig. 4. Nitrotyrosine staining in distal tubules.
ing tyrosine, and hence, we are confident that we are
detecting the presence of ONOOx activity.
The presence of nitrotyrosine has previously been
demonstrated in renal tubular cells of patients with
chronic allograft rejection. In the same study, exposure
to ONOOx was associated with nitration and inactivation
of Ox dismutase, leading to irreversible oxidative injury
to mitochondria [25]. To our knowledge, this is the first
study to confirm the presence of ONOOx production the
proximal tubules of patients with biopsy-proven DM. It
is interesting to note the lack of presence of apoptotic
elements in the proximal tubules of the diabetics. It has
been suggested that ONOOx causes damage by inducing
the apoptotic pathway [26]. Clearly, there is no evidence
for this action in the samples studied. Apoptosis, how-
ever, is a very rapid process, and absence of such cells
on a biopsy specimen does not exclude the presence of
this process.
Fig. 3. Nitrotyrosine staining in descending limbs. Hyperglycemia-induced free radical generation may
be derived from the polyol pathway of glucose metabo-
lism [27], nonenzymatic glycation (advanced glycation
end products) [16], glucose autoxidation [28], enhancedDISCUSSION
arachidonic acid metabolism [29], and up-regulation of
The results of this study clearly demonstrate that in cytochrome p450 2E1 isoform (abstract; Varagunam Proc
patients with DM, excessive ONOOx is produced in the XIVth Int Congr Nephrol 3:S44, 1997) [30]. Furthermore,
proximal tubular cells and may be an important mediator excessive NOx in DM may be produced because of associ-
of tubulointerstitial injury. The antibody used for this ated interstitial ischemia [11] or de novo induction of
study is a polyclonal antibody against nitrotyrosine, first inducible NOS [21]. The resultant ONOOx production
used by Beckmann et al to detect the presence of nitroty- is therefore subject to therapeutic manipulation by selec-
rosine in human vessels [23] and in subsequent studies tive inhibition of the predominant pathway involved.
was used to detect the presence of nitrotyrosine in lung It is interesting to note the presence of nitrotyrosine
tissue. In these studies, the antibody was shown to be in the collecting ducts and distal tubules in all five groups.
specific for nitrotyrosine [24]. In this study, all positive This could be explained by the presence of constitutive
controls showed specific staining for nitrotyrosine, and NOS (cNOS) in the juxtaglomerular apparatus, which
negative controls showed no staining. There is no evi- has now been clearly demonstrated [31]. The source of
the superoxide in this context may be cNOS itself, as itdence that any other compound is capable of nitrosylat-
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H, White MC, Bell GM: Relationship between markers of endo-can generate O2x and NOx in equal amounts [32], which thelial dysfunction, oxidant injury and tubular damage in patients
potentially could result in ONOOx formation. The lack with insulin dependent diabetes mellitus. Clin Sci 85:557–562, 1993
12. Yaqoob M, McClelland P, Stevenson A, Mason H, White MC,of toxicity of ONOOx in the distal tubules may be due
Bell GM: Evidence of oxidant injury and tubular damage in earlyto the presence of efficient endogenous defense mecha-
diabetic nephropathy. Q J Med 87:601–607, 1994
nisms, or that the amount produced is not sufficient to 13. Deleted in proof.
14. Jennings PE, Jones AF, Florkowski CM, Lunec J, Barnett AH:cause cell injury [33]. Further work is needed to identify
Increased diene conjugates in diabetic subjects with microangiopa-natural defense mechanisms that will be useful to attenu-
thy. Diabet Med 4:452–457, 1987
ate its toxicity under pathological condition. 15. Cross CE, Halliwell B, Borish ET, Pryor WA, Ames BN, Saul
RL, McCord JM, Harman D: Oxygen radicals and human disease.In summary, we have clearly demonstrated evidence
Ann Intern Med 107:526–545, 1987of ONOOx-mediated nitrosylation of tyrosine moieties
16. Bucala R, Tracey KJ, Cerami A: Advanced glycosylation prod-
of cellular proteins in the proximal tubules of patients ucts quench nitric oxide and mediate defective endothelium-depen-
dent vasodilation in experimental diabetes. J Clin Invest 87:432–with DM. Moreover, the absence of nitrotyrosine in other
438, 1991types of nephropathies indicates that this pathway is spe-
17. Craven PA, Studer RK, DeRubertis FR: Impaired nitric oxide-
cific for DM. These data suggest that antioxidant therapy dependent cyclic guanosine monophosphate generation in glomer-
uli from diabetic rats. J Clin Invest 93:311–320, 1994may have a potential role for the prevention of DM.
18. Knowles RG, Moncada S: Nitric oxide synthases in mammals.
Biochem J 298:249–258, 1994
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